Business Context and Reporting Period
This Form 8-K reports on the 2017 Annual Meeting of Stockholders held by TherapeuticsMD, Inc. on June 16, 2017. The filing details the voting results for three specific proposals submitted to shareholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is a corporate governance report focused solely on shareholder voting outcomes.
Material Changes and Voting Results
The following proposals were voted upon and adopted by the stockholders:
- Proposal 1 (Election of Directors): All ten nominees were elected. The total votes cast "For" ranged from approximately 141.3 million to 152.2 million per nominee. There were zero votes "Against" any nominee. Abstentions ranged from approximately 692,000 to 11.6 million. Broker non-votes totaled 31,719,830 for all nominees.
- Proposal 2 (Say-on-Pay): The non-binding advisory vote on executive compensation for the fiscal year ended December 31, 2016, was approved. Votes "For" totaled 150,902,446, while votes "Against" totaled 1,784,583. Abstentions were 219,991.
- Proposal 3 (Auditor Ratification): The appointment of Grant Thornton, LLP as the independent auditor for the fiscal year ending December 31, 2017, was ratified. Votes "For" totaled 184,022,279, with 482,210 votes "Against" and 122,361 abstentions. There were no broker non-votes for this proposal.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It strictly reports the final voting tallies for the annual meeting.
Important Facts for Investors to Verify
- Verify the total number of shares outstanding to contextualize the voting percentages, as the filing only provides raw vote counts.
- Review the 2017 Proxy Statement (filed April 25, 2017) for detailed biographies of the elected directors and the specific compensation metrics approved in Proposal 2.
- Confirm the independence and qualifications of Grant Thornton, LLP as the newly ratified auditor for the 2017 fiscal year.